EUVIMEDEUVIMED entdecken
Crossref

INVESTIGATION OF URSODEOXYCHOLIC ACID EFFECTS ON SIROLIMUS TREATED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS

Esra ARISU NAGHAVI, Bakiye GOKER BAGCA, Senem TEKELİ, Gürkan YİĞİTTÜRK, Burak GÖKÇE, Canberk TOMRUK, Türker ÇAVUŞOĞLU, Çığır AVCI, Cumhur GÜNDÜZ, Yiğit UYANIKGİL

SDÜ Tıp Fakültesi Dergisi · 2022

DOI: 10.17343/sdutfd.1077520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SDÜ Tıp Fakültesi Dergisi, 2022. Verfasst von Esra ARISU NAGHAVI und 9 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Ege University Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The usage of mesenchymal stem cells (MSC) with immunosuppressive drugs after organ transplantation is becoming remarkable in clinical applications. However, the drugs negatively affect MSCs. Ursodeoxycholic acid (UDCA), which is an antioxidant molecule, may reverse these effects. The study aims that to determine the effects of sirolimus and UDCA on human adipose tissue-derived MSCs (ADMSCs) individually and in combination. Material and Method The cytotoxicity of the agents was evaluated by WST-1 test in time and dose-dependent manner. The combinational effects were determined using isobologram analysis. Muse cell analyzer was used for the evaluation of apoptosis and cell cycle. Oxidative stress markers were measured by biochemical methods.

Results

IC50 dose of sirolimus was determined as 18.58μM in the 48th hour. Because no cytotoxic effect was observed at the studied doses of UDCA, the apoptosis, cell cycle, and oxidative stress indicator analyses were continued with a safe dose of 100 μM. Sirolimus promoted apoptosis and inhibited cell proliferation. It was determined that UDCA reduced the apoptotic and anti-proliferative effects of sirolimus on ADMSCs with its anti-oxidant property.

Conclusion

The UDCA treatment in combination with immunosuppressive therapy after organ and tissue transplantation may have positive effects on ADMSCs.

Förderung

  • Ege University Research Foundation

Zitieren

APA

NAGHAVI, E. A., BAGCA, B. G., TEKELİ, S., YİĞİTTÜRK, G., GÖKÇE, B., TOMRUK, C., ÇAVUŞOĞLU, T., AVCI, Ç., GÜNDÜZ, C., & UYANIKGİL, Y. (2022). INVESTIGATION OF URSODEOXYCHOLIC ACID EFFECTS ON SIROLIMUS TREATED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS. SDÜ Tıp Fakültesi Dergisi. https://doi.org/10.17343/sdutfd.1077520

Vancouver

NAGHAVI EA, BAGCA BG, TEKELİ S, YİĞİTTÜRK G, GÖKÇE B, TOMRUK C, et al. INVESTIGATION OF URSODEOXYCHOLIC ACID EFFECTS ON SIROLIMUS TREATED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS. SDÜ Tıp Fakültesi Dergisi. 2022. doi:10.17343/sdutfd.1077520

BibTeX
@article{NAGHAVI2022,
  author = {NAGHAVI, Esra ARISU and BAGCA, Bakiye GOKER and TEKELİ, Senem and YİĞİTTÜRK, Gürkan and GÖKÇE, Burak and TOMRUK, Canberk and ÇAVUŞOĞLU, Türker and AVCI, Çığır and GÜNDÜZ, Cumhur and UYANIKGİL, Yiğit},
  title = {INVESTIGATION OF URSODEOXYCHOLIC ACID EFFECTS ON SIROLIMUS TREATED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS},
  journal = {SDÜ Tıp Fakültesi Dergisi},
  year = {2022},
  doi = {10.17343/sdutfd.1077520}
}
Kostenlos starten →